January 7, 2026

A new policy is now available in our Policy Bulletin Library. Effective 02/09/2026, we will be implementing a new drug policy: DR.024.A Encelto (revakinagene taroretcel-lwey).

You can access this policy by visiting our Policy Bulletin Library.

As a reminder, our medical policy bulletins define medical necessity criteria and coverage positions on topics such as medical services, procedures, DME, therapies, etc., while our claim payment policy bulletins provide reimbursement rules and billing guidelines necessary to ensure timely and appropriate payment.

Thank you for your support in providing the highest quality of care to our members.